Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M85,881Revenue (TTM) $M22,292Net Margin (%)15.6Altman Z-Score1.6
Enterprise Value $M99,818EPS (TTM) $1.3Operating Margin %22.0Piotroski F-Score4
P/E(ttm)24.3Beneish M-Score-2.4Pre-tax Margin (%)15.8Higher ROA y-yY
Price/Book6.210-y EBITDA Growth Rate %-2.4Quick Ratio0.6Cash flow > EarningsN
Price/Sales3.85-y EBITDA Growth Rate %-12.5Current Ratio0.8Lower Leverage y-yY
Price/Free Cash Flow112y-y EBITDA Growth Rate %23.4ROA % (ttm)5.6Higher Current Ratio y-yN
Dividend Yield %4.1PEG--ROE % (ttm)25.7Less Shares Outstanding y-yN
Payout Ratio %105Shares Outstanding M2,532ROIC % (ttm)17.3Gross Margin Increase y-yN

Gurus Latest Trades with AZN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

AZN is held by these investors:



AZN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ASTRAZENECA PLC10% Owner 2014-11-12Sell2,000,000$1799.12view

Quarterly/Annual Reports about AZN:

    News about AZN:

    Articles On GuruFocus.com
    Charles Brandes Invests in Health Care in 1st Quarter May 11 2017 
    FibroGen Announces China FDA Approval of CTA to Conduct Pivotal Phase 2/3 Clinical Trial of Roxadust Mar 31 2017 
    Causeway International Value Buys AstraZeneca, Gildan Mar 09 2017 
    Dodge & Cox Comments on AstraZeneca Feb 06 2017 
    FibroGen’s Roxadustat (FG-4592) Meets Primary Endpoints in Two Phase 3 Anemia Studies in China Jan 30 2017 
    SCYNEXIS Announces Appointment of Industry Veteran Marion McCourt to its Board of Directors Jan 26 2017 
    Dodge & Cox's Stock Fund 4th Quarter Commentary Jan 16 2017 
    Big Alzheimer Flop Creates Buying Opportunity for Eli Lilly Dec 10 2016 
    8 Uncommon Stocks NWQ Managers Is Buying Dec 06 2016 
    How Could a Potential Nexium Lawsuit Affect AstraZeneca? Nov 03 2016 

    More From Other Websites
    AstraZeneca recalls physician sample bottles of heart drug May 26 2017
    AstraZeneca Delivers New Data on Expanding Portfolio of Cancer Medicines at 2017 American Society of... May 26 2017
    AstraZeneca Initiates Voluntary Nationwide Recall of One Lot of BRILINTA 90mg Professional Sample... May 25 2017
    Performance of Merck’s Diabetes Portfolio in 1Q17 May 24 2017
    AstraZeneca's Bydureon Fails to Reduce Cardiovascular Risk May 24 2017
    The Zacks Analyst Blog Highlights: Oracle, Chubb, AstraZeneca, Estee Lauder and Aflac May 24 2017
    Novo Nordisk Diabetes Lead Unscathed Following AstraZeneca Trial May 23 2017
    New Research Reports for Oracle, Chubb, AstraZeneca & Others May 23 2017
    AstraZeneca Sells Marketing Rights to Seloken in Europe May 23 2017
    AstraZeneca PLC (AZN): Strong Industry, Solid Earnings Estimate Revisions May 23 2017
    BYDUREON EXSCEL Trial Meets Primary Safety Objective in Type-2 Diabetes Patients at Wide Range of... May 23 2017
    AstraZeneca Shares Rise as Investors Shrug Off Mixed Diabetes Results May 23 2017
    Astrazeneca (AZN) Gets Positive CHMP Opinion for Brodalumab May 22 2017
    Phase III ZONDA Trial for benralizumab Shows Ability to Reduce Oral Steroid Use in Severe Asthma... May 22 2017
    Severe asthma drug shows AstraZeneca promise beyond cancer May 22 2017
    [$$] AstraZeneca sells Seloken European rights for $300m May 22 2017
    AstraZeneca sells ageing beta-blocker to Recordati for $300 mln May 22 2017
    Big Pharma Stock Astrazeneca Gets Relative Strength Upgrade May 18 2017
    Vertex Pharmaceuticals' Shares Pop in Afterhours Trading After FDA Approval while AstraZeneca Sinks... May 18 2017
    Did AstraZeneca Rival Just Launch A Potential Blockbuster Drug? May 17 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)